Literature DB >> 7566612

Interdialysis blood pressure control by long haemodialysis sessions.

C Chazot1, B Charra, G Laurent, C Didier, C Vo Van, J C Terrat, E Calemard, T Vanel, M Ruffet.   

Abstract

High blood pressure (BP) is a major factor contributing to the high incidence of cardiovascular morbidity and mortality in haemodialysis (HD) patients. According to predialysis casual BP measurements, long HD has been shown to provide good BP control. To confirm this result during the period between dialysis sessions, we performed ambulatory monitoring of BP in 91 non-selected HD patients (mean age, 58.7 (14.1) years; 14% incidence of nephrosclerosis and diabetes mellitus; treatment duration, 93.0 (77.2) months; 3 x 8 h/week, cuprophane, acetate buffer in 95% of the patients). Only one patient (1.1%) was receiving an antihypertensive medication. Ambulatory BP results were systolic (S) BP, 119.4 (19.9) mmHg; diastolic (D) BP, 70.6 (12.9) mmHg; mean (M) BP, 87.6 (13.9) mmHg. These values were significantly lower than the casual predialysis BP data and close to the reference values reported by Staessen et al. in a meta-analysis including 3476 normotensive subjects. The MBP was inversely correlated with the treatment duration, but not with interdialysis weight gain. The MBP increased significantly in the last part of the interdialysis period, and this rise was not correlated with the interdialysis weight gain. The nocturnal/diurnal ratios for SBP and DBP for the HD patients (0.97 and 0.92) were higher than the reference values reported by Staessen, (0.87 and 0.83), and argued against a nocturnal decrease in BP. We found that 52.1% of the patients had an abnormal nocturnal BP fall (MBP fall < 5%). This feature worsened during the second night of the interdialysis period.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7566612

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  13 in total

Review 1.  Circadian rhythm of blood pressure in renal disease.

Authors:  M Schömig; V Schwenger; E Ritz
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

Review 2.  Home haemodialysis and uraemic toxin removal: does a happy marriage exist?

Authors:  Raymond Vanholder; Sunny Eloot; Nathalie Neirynck; Wim Van Biesen
Journal:  Nat Rev Nephrol       Date:  2012-08-28       Impact factor: 28.314

Review 3.  Setting the dry weight and its cardiovascular implications.

Authors:  Arjun D Sinha; Rajiv Agarwal
Journal:  Semin Dial       Date:  2017-06-30       Impact factor: 3.455

4.  The effect of dietary salt on blood pressure in individuals receiving chronic dialysis: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Nicholas I Cole; Pauline A Swift; Feng J He; Graham A MacGregor; Rebecca J Suckling
Journal:  J Hum Hypertens       Date:  2018-11-09       Impact factor: 3.012

5.  Shorter delivered dialysis times associate with a higher and more difficult to treat blood pressure.

Authors:  Teena Tandon; Arjun D Sinha; Rajiv Agarwal
Journal:  Nephrol Dial Transplant       Date:  2013-01-24       Impact factor: 5.992

6.  Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients.

Authors:  Jula K Inrig; Uptal D Patel; Barbara S Gillespie; Vic Hasselblad; Jonathan Himmelfarb; Donal Reddan; Robert M Lindsay; James F Winchester; John Stivelman; Robert Toto; Lynda A Szczech
Journal:  Am J Kidney Dis       Date:  2007-07       Impact factor: 8.860

Review 7.  The advantages and challenges of increasing the duration and frequency of maintenance dialysis sessions.

Authors:  Charles Chazot; Guillaume Jean
Journal:  Nat Clin Pract Nephrol       Date:  2008-11-25

8.  Daily ultrafiltration results in improved blood pressure control and more efficient removal of small molecules during hemodialysis.

Authors:  James P Jones; Edward F Leonard; Gagangeet Sandhu; Gary Winkel; Nathan W Levin; Stanley Cortell
Journal:  Blood Purif       Date:  2013-01-08       Impact factor: 2.614

Review 9.  Assessment and management of hypertension in patients on dialysis.

Authors:  Rajiv Agarwal; Joseph Flynn; Velvie Pogue; Mahboob Rahman; Efrain Reisin; Matthew R Weir
Journal:  J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 10.121

10.  Escalating antihypertensive medications in end-stage renal disease patients does not improve blood pressure control.

Authors:  Mihály Tapolyai; Jariatul Karim; Atif Fakhruddin
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-03       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.